首页> 外文OA文献 >Predicting Survival in Patients Undergoing Chemoradiation for Locally Advanced Non-Small Cell Lung Cancer (LA-NSCLC) Using Mid-Treatment Imaging Response and Radiation Parameters

【2h】

Predicting Survival in Patients Undergoing Chemoradiation for Locally Advanced Non-Small Cell Lung Cancer (LA-NSCLC) Using Mid-Treatment Imaging Response and Radiation Parameters

机译：使用中等治疗成像响应和辐射参数预测局部晚期非小细胞肺癌（LA-NSCLC）患者的生存期

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
J. Zeng; H.M.T. Thomas; R. Rengan; D.S. Hippe; H.J. Vesselle; P.E. Kinahan; S.R. Bowen;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Predictors of Long-Term Survival Among Locally Advanced Non-small Cell Lung Cancer Patients Undergoing Definitive Radiation Therapy [J] . Bazzi L., Boonstra P. S., Soni P. D., International Journal of Radiation Oncology, Biology, Physics . 2017,第2Suppla期

机译：局部晚期非小细胞肺癌患者的长期存活预测因子进行明确放射治疗
2. Presence of Giant Circulating Cancer-Associated Macrophage-like Cells after Definitive Chemoradiation Predicts for Progression in Locally Advanced Non-Small Cell Lung Cancer Patients [J] . Augustyn A., Adams D. L., He J., International Journal of Radiation Oncology, Biology, Physics . 2019,第1Suppla期

机译：在明确的校长后，存在巨型循环癌症相关的巨噬细胞样细胞在局部晚期非小细胞肺癌患者中的进展预测
3. The benefit of treatment intensification is age and histology-dependent in patients with locally advanced non-small cell lung cancer (NSCLC): a quality-adjusted survival analysis of radiation therapy oncology group (RTOG) chemoradiation studies. [J] . Movsas B, Scott C, Sause W, International Journal of Radiation Oncology, Biology, Physics . 1999,第5期

机译：对于局部晚期非小细胞肺癌（NSCLC），加强治疗的益处是年龄和组织学依赖性：放射治疗肿瘤学组（RTOG）化学放射研究的质量调整后生存分析。
4. Gene expression profiles predict survival of patients with advanced non-small cell lung cancers [C] . Harun Roslan, Hadi Jalal, Mhazir Nur Shukriyah, 2011 Fourth International Conference on Modeling, Simulation and Applied Optimization . 2011

机译：基因表达谱预测晚期非小细胞肺癌患者的生存
5. Modeling Dose-Function Response and Toxicity Pathways in Non-Small Cell Lung Cancer Patients Undergoing Radiation Treatment [D] . Owen, Daniel Rockwell. 2021

机译：非小细胞肺癌患者辐射治疗中的剂量函数响应和毒性途径
6. Predicting per-lesion local recurrence in locally advanced non-small cell lung cancer following definitive radiation therapy using pre- and mid-treatment metabolic tumor volume [O] . Michael S. Binkley, Julie L. Koenig, Mehr Kashyap, 2020

机译：使用治疗前和治疗中新陈代谢肿瘤体积的明确放疗后预测局部晚期非小细胞肺癌的病灶局部复发
7. Using the Systemic Inflammation Index (SII) as a Mid-Treatment Marker for Overall Survival among Patients Undergoing Chemo-Radiation Therapy for Stage-III Locally Advanced Non-Small Cell Lung Cancer (NSCLC): Secondary Analysis of PROCLAIM Trial [O] . T. Biswas, K.H. Kang, D. Bajor, 2020

机译：使用全身炎症指数（SII）作为中期治疗标志物，用于在进行化疗 - III局局部晚期非小细胞肺癌（NSCLC）的患者中的整体存活中的总生存：宣告试验的二次分析

Predicting Survival in Patients Undergoing Chemoradiation for Locally Advanced Non-Small Cell Lung Cancer (LA-NSCLC) Using Mid-Treatment Imaging Response and Radiation Parameters

著录项

引文网络

相似文献

相关主题

期刊订阅